Floatz logo

sl-279252

Mismatch Repair Deficient or MSI-High Solid Tumors

Shattuck Labs, Inc.Phase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

11 Active assets in the Mismatch Repair Deficient or MSI-High Solid Tumors cohort.

Asset / SponsorPhaseRating
Carboplatin
Shanghai Zhongshan Hospital
Phase 2CCC
Shr-8068
Shanghai Zhongshan Hospital
Phase 2CCC
Capecitabine
Shanghai Zhongshan Hospital
Phase 2CCC
Eloxatin
Shanghai Zhongshan Hospital
Phase 2CCC
Adebrelimab
Shanghai Zhongshan Hospital
Phase 2CCC

View all 11 →

Same molecule, other indications

sl-279252 is also rated in:

head and neck squamous cell carcinomaDormant
CC
Indicative ·
47 / 100
View asset →
anal squamous cell carcinomaDormant
CC
Indicative ·
47 / 100
View asset →
cervical squamous cell carcinomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →